METAvivor Announces the Virtual Conference: Overcoming Health Disparities In MBC
Michimich.com/10139746

ANNAPOLIS, Md. - Michimich -- METAvivor Research and Support, Inc. announces an engagement conference to help those in the healthcare setting, research and within the patient community to share information about health disparities in metastatic breast cancer (MBC) and to bring healthcare providers, researchers, patients and caregivers together to discuss and develop actionable strategies to overcome these disparities in MBC. The conference will feature thought leaders in the metastatic breast cancer community and will have a unique roundtable discussion to develop key tasks that will lead toward the goal of eliminating disparities.

According to Jamil Rivers, president of METAvivor "We are excited to host this powerful virtual conference that will allow us to leave with actionable strategies to overcome disparities in metastatic breast cancer. We are so thankful to our title sponsor, Astrazenaca and our platinum sponsors Eisai Global and Lilly Oncology for recognizing the importance of this topic and helping METAvivor make this conference a reality."

More on Michimich.com

• Michigan: Video documents M-185 Mackinac Island repair project
• Michigan: US-12/M-50 intersection culvert replacements in Brooklyn begin Monday
• Michigan: AG Nessel Urges U.S. Supreme Court To Halt Unconstitutional Texas Abortion Ban Through Multistate Amicus Brief
• Michigan: US-127 lane closures at M-50 in Jackson County begin Tuesday for deck repairs
• With The Holidays Near And Retail Crime Up, Stores Begin Adding Security Guards

The virtual conference is a two-day, 3.5 hour conference beginning on Friday, September 24 from 5:30 pm EDT and reconvening on Saturday, September 25 at 10:30 am EDT. The event will open with an exhibit hall that includes partners and sponsors of the program. For more information or to register, go to https://pheedloop.com/METAvivor/site/home/

About Metastatic Breast Cancer
Metastatic breast cancer also known as stage IV or advanced breast cancer, occurs when the cancer has spread from the breast to other parts of the body.  This usually includes the lungs, liver, bones or brain. 115 women and men die each day from metastatic breast cancer. There is no cure for metastatic breast cancer. Although there are treatments and therapies for those living with the disease the median life span remains 33 months.

Racial Disparities in Breast Cancer
The overall rate of breast cancer is similar for black and white women, although black women are 42 percent more likely to die from the disease. Other disparities for black women compared with white women include a higher rate of breast cancer before age 40, a greater likelihood of being diagnosed at a late stage and an increased risk of having triple-negative breast cancer, which tends to be more aggressive.

More on Michimich.com

• Michigan: DNR's Western UP Citizens' Advisory Council to meet in Marquette County
• Michigan: M-28 Munising project winds down for the season
• Michigan: Geddes Road ramp to US-23 closed for bridge hit damage inspection
• Beautyforever Hair Halloween Sale: Up to 58% Off
• Two Women From Different Countries Create a Skincare Brand That Illuminates Melanin Skin

About METAvivor
METAvivor Research and Support Inc.  is a non-profit organization with a primary mission to fund critical research that will lead to advances in treatment options, improve quality of life and survival for patients diagnosed with metastatic breast cancer.  METAvivor has awarded 135 research grants totaling over $18 million. METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.

METAvivor also raises awareness of MBC, provides support for people living with the terminal disease, and offers opportunities for others to help make a difference for the metastatic community. METAvivor has gained a rapidly growing following within the breast cancer community and has become a leader in in metastatic breast cancer research.